All references

Revolutionizing Cardiovascular Care: Veracell is Joining the CVDLINK Initiative

CVDLINK is a visionary initiative under the Horizon Europe Program aimed at transforming the management of cardiovascular diseases (CVDs) across Europe. Leveraging advanced technology and data-driven approaches, we're on a mission to innovate preventive measures, improve patient outcomes, and set new standards in cardiovascular care.

  • Development of a privacy-by-design, European-wide federated platform-as-a-service (PaaS).

  • Leveraging real-world data for the betterment of diagnosis, prognosis, and risk assessment of CVDs.

  • Enabling seamless and legally compliant integration, sharing, and automated curation of data.

We're proud to share our involvement in the groundbreaking CVDLINK project, backed by the Horizon Europe Program. The challenge we face is monumental, with over 6 million new cases of cardiovascular disease (CVD) and 1.8 million deaths annually in the EU alone. The urgency for innovative and effective preventive measures has never been greater. Through CVDLINK, we aim to revolutionize the management of CVDs, leveraging cutting-edge technology and data-driven strategies to make a significant impact.

At the core of our mission within CVDLINK is the development of a privacy-by-design, European-wide federated platform-as-a-service (PaaS). This platform is the cornerstone of our approach, enabling the seamless and legally compliant integration, sharing, and automated curation of data. Alongside this, we are developing a suite of AI and data-enabled precision medicine tools. These tools are designed to advance research, improve patient outcomes, and ultimately transform the way we diagnose, stratify risk, and treat CVDs.

Our role in this consortium, alongside 18 other partners, signifies our commitment to leveraging real-world data for the betterment of diagnosis, prognosis, and risk assessment of CVDs. By examining seven different cardiovascular conditions across seven countries, we are setting a new standard in how diverse data sources can be effectively utilized. Our goal is to build comprehensive AI-driven tools that will not only benefit health systems and patients but also contribute positively to the well-being of EU citizens at large.

The impact of our work in CVDLINK will be demonstrated through the prospective validation of the developed tools in five countries. Furthermore, we are committed to generating a set of best practices, conducting a cost-effectiveness analysis, and leading systematic awareness-raising campaigns. These efforts are geared towards ensuring the wide adoption of CVDLINK's outcomes, setting a new benchmark in the fight against cardiovascular diseases.

Join us at Veracell on this transformative journey with CVDLINK, as we work towards a future where CVDs can be effectively prevented and managed. Together, we're not just aiming for better health outcomes; we're working to revolutionize cardiovascular care, ensuring a healthier tomorrow for all.

Our team

Timo Erkkilä
CEO, AI Advisor & Sales
Emmi Hämäläinen
Lead Scientist

From the blog

Our collaborations — imagining together

Intrigued?

These glimpses are just the tip of the iceberg. Together, let's turn your "what-ifs" into "how-tos," shaping a future we dare to dream.

Contact us